Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease, Carl E Clarke and Katherine Deane. DOI: 10.1002/14651858.CD001519
Complete the form below and we will send an e-mail message containing a link to the selected mrwArticle on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.